Yasuhiro Shimada

机构：CHI Health, Kochi Health Sciences Center · ORCID：0000-0003-1385-696X

发表论文 524 篇 · 总被引 23151 次 · h-index 57

代表论文

• Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial (2021 · Journal of Clinical Oncology · 被引 204)
• The Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006) (2021 · Annals of Surgery · 被引 39)
• A randomized phase III trial of mFOLFOX7 or CapeOX plus bevacizumab versus 5-FU/l-LV or capecitabine plus bevacizumab as initial therapy in elderly patients with metastatic colorectal cancer: JCOG1018 study (RESPECT). (2022 · Journal of Clinical Oncology · 被引 17)
• Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer (2023 · Annals of Surgery · 被引 13)
• Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG1702A (2020 · Japanese Journal of Clinical Oncology · 被引 13)
• Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study (2023 · Scientific Reports · 被引 8)